SpeeDx Receives CARB-X Funding to Develop Rapid Point-of-Care Diagnostic
CARB-X is featured.
Pfizer Buys Amplyx to Expand Drug-Resistant Treatment Portfolio
Kevin Outterson is quoted.
April 28, 2021 Channel News AsiaPhico Therapeutics Awarded up to $18.2 Million Funding to Advance Antibacterial Therapy
CARB-X is mentioned.
Baebies Awarded up to $11.6 Million from CARB-X for the Development of a Diagnostic Platform with Rapid Results for Sepsis
CARB-X is mentioned.
Novel Microdevices, Inc. Awarded up to $13.8 Million from CARB-X for the Development of a Rapid, Point-of-Care, Molecular Diagnostic Platform for the Detection of Sexually Transmitted Diseases, Including Antibiotic-Resistant Infections
CARB-X is featured.
Scientists are Working on a ‘Super Gonorrhea’ Vaccine to Treat an Antibiotic-Resistant Strain of the Infection
Carb-X is mentioned.
April 2, 2021 InsiderNew Framework Released for Responsible Use of Antibiotic Treatments
Kevin Outterson is quoted.
March 23, 2021 European Pharmaceutical Manufacturer MagazineAffinivax Announces Award from CARB-X for up to $22 Million to Advance its Staphylococcus aureus MAPS™ Vaccine Candidate into Clinical Trials
CARB-X is featured.
The Next Pandemic? It May Already Be Upon Us
Kevin Outterson is quoted.
February 16, 2021 The GuardianPush and Pull: Funding Drugs to be Used Only Sparingly
Kevin Outterson is quoted.
February 14, 2021 The Financial Times